Lotte Holdings Signs Pharmaceutical Contract Manufacturing Agreement Worth 283.3 Billion KRW
[Asia Economy Reporter Kang Nahum] Lotte Holdings announced on the 16th that it has signed a contract for pharmaceutical contract manufacturing with the multinational pharmaceutical company Bristol-Myers Squibb Company and its affiliates.
Hot Picks Today
"Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "Sold Everything Fearing Bankruptcy, Then It Soared 3,900 Times: How a Stock Once Feared for Delisting Became an AI Powerhouse"
- "All Major Corporations Could Leave"... Business Community Fears Overseas Factory Relocation Due to Strike Risks
- Fiscal Pressure Mounts Amid Surging U.S. Treasury Yields...Exceeds Supplementary Budget Estimate by 0.04%p
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
The contract amount is 283.36 billion KRW, which corresponds to 2.85% of the previous year's sales revenue.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
